The Pharma Data

SEPTEMBER 6, 2021

First data to be presented from the phase II coopERA Breast Cancer study evaluating neoadjuvant giredestrant treatment for oestrogen receptor (ER)-positive, HER2-negative breast cancer. In CUP, doctors cannot identify the location of the original (primary) tumour and can only find metastases. Breast Cancer Highlights.

Treatment 52

Treatment Therapies DNA Trials 52

The Pharma Data

SEPTEMBER 29, 2020

Prof John Wright, a doctor and epidemiologist, is head of the Bradford Institute for Health Research, and a veteran of cholera, HIV and Ebola epidemics in sub-Saharan Africa. Earlier this month, though, someone who’d attended the temple tested positive for Covid-19 and all those present on the same day had to self-isolate for two weeks.

Doctors 52

Doctors Trials Virus Government 52

On Medicine

FEBRUARY 8, 2024

This is in contrast to reactive deprescribing, which is stopping a medicine in response to present harm, e.g., when side effects of a medicine cause a person to fall. In previous research by members of the CHARMER team, older people and their carers told us that they would like their medicines reviewed by doctors during their hospital stay.

Hospitals 109

Hospitals Trials Doctors Clinical Research 109

SCIENMAG: Medicine & Health

MARCH 20, 2024

Milan, Italy: Using a combined scanning technique on patients with early-stage breast cancer improved treatment in almost three out of ten cases in a trial presented at the 14th European Breast Cancer Conference today (Thursday). [1]

Treatment 68

Treatment Doctors Trials 68

SCIENMAG: Medicine & Health

AUGUST 8, 2023

On September 13-14, 2023, Queen Mary University of London will host the annual iGGi Con, organised by the EPSRC Centre for Doctoral Training in Intelligent Games and Game Intelligence (iGGi). Registration for the conference is now open, and early registration is recommended as places are limited.

Research 70

Research Doctors Science 70

Drug Target Review

JANUARY 12, 2024

For example, circulating tumour cells in the blood can give evidence of whether the tumour is still present and what kind of genetic makeup it has, like if the tumour is still harbouring the original mutations that was used to determine the original course of treatment, or has it changed?

Doctors 111

Doctors Clinical Trials Treatment Therapies 111

The Pharma Data

JANUARY 14, 2021

COHASSET, MA, January 14, 2021 /24-7PressRelease/ — Marquis Who’s Who, the world’s premier publisher of biographical profiles, is proud to present Harvey Leonard Dickstein, MD, with the Albert Nelson Marquis Lifetime Achievement Award. More recently, he was a member of the Cohasset Board of Health between 2015 and 2018.

Laboratories 52

Laboratories Clinical Research Hospitals Pharmaceuticals 52

The Pharma Data

DECEMBER 29, 2020

“It’s an ever-present challenge for everyone, independent of where they are.” Benjamin hopes he can spend more time in the present, “so that I can be a catalyst and, hopefully, a positive force for everything that’s around me.” Just do the math, and you’re going to get there.”

Doctors 52

Doctors Research 52

The Pharma Data

JULY 21, 2021

– Allergan, an AbbVie (NYSE: ABBV) company, today announced that it will present new data from its leading portfolio of eye care medicines at the 2021 ASCRS (American Society for Cataract and Refractive Surgery) Annual Meeting being held July 23-27 in Las Vegas, NV. Details about Allergan’s presentations are as follows: .

Treatment 52

Treatment Doctors Production FDA Approval 52

keypoint

OCTOBER 26, 2023

In fact, when Dr. Jim Allison first attended as a post-doctoral fellow, he presented at a workshop in the Tumor Immunology conference, which at the time was focused on investigating the involvement of the immune system in cancer progression.

Doctors 77

Doctors 77

National Drug & Alcohol Research Centre Blog

NOVEMBER 21, 2023

38 NDARC attendees (plus five virtual attendees) shared their research during two keynote presentations, 20 oral presentations, 11 poster presentations, one-panel session, one clinical trial stand, and plenty of lunchtime networking. Sara giving her keynote presentation. Rebecca giving her keynote presentation.

Clinical Trials 72

Clinical Trials Trials Doctors Research 72

KIF1A

OCTOBER 21, 2023

Several KAND-related mutations have been identified in the PH domain, presenting as hereditary and sensory neuropathy (HSAN KAND) or spastic paraplegia phenotypes; investigating its role in KIF1A biology can help us better understand and address KAND progression and subtypes.

Regulations 105

Regulations Doctors Disease Packaging 105

Broad Institute

JANUARY 18, 2024

But the body presents a significant challenge. The ability to get peak activity of these agents within a couple of hours, followed by their rapid clearance, means that someone could go to their doctor's office, receive an agent like this, and then give their blood for the test itself, all within one visit,” Love said.

DNA 133

DNA Engineering Science Disease 133

KIF1A

MAY 24, 2023

A New Opportunity: the KIF1A Research Network in Action KIF1A.ORG was presented with such an opportunity by teaming up with Dr. Rebecca Shi of Stanford University, who worked to create a research laboratory course for undergraduates in the Stanford Biology department for the Spring 2023 semester. “You These are our future doctors.

Disease 98

Disease Laboratories Research Science 98

Drug Target Review

DECEMBER 13, 2023

This is likely indicative of the heterogeneous nature of the disorder, and it is this complexity and diversity of clinical presentation and effects across multiple organ systems, that has made efforts to identify genetic risk factors using traditional genomic analysis approaches extremely challenging.

Bioinformatics 145

Bioinformatics Disease Regulations Immune Response 145

Perficient: Drug Development

SEPTEMBER 11, 2023

I jokingly started calling myself “Docker Doctor” ⁠( ⁠ ). That presented a whole new set of challenges; languages, shared and versioned content, fallback languages, and more. I did not want to follow article after article of troubleshooting tips that may or may not solve the problem. I really enjoyed writing this series.

Doctors 104

Doctors 104

Conversations in Drug Development Trends

NOVEMBER 10, 2023

At this year’s annual Pain Therapeutics Summit , which took place in San Diego, CA, October 19 to 20th, I heard brilliant presentations on novel pain medication development, targeted discoveries, pain classifications, the NIH HEAL Initiative , trial designs, biomarkers, and others.

Clinical Trials 75

Clinical Trials Trials Treatment Compliance 75

FDA Law Blog: Biosimilars

DECEMBER 4, 2023

12, 2012). “[W]hen the circumstances surrounding the presentation of a prescription would give rise to suspicion in a ‘reasonable professional,’ there is a duty to question the prescription.” Holiday CVS, L.L.C. d/b/a CVS/Pharmacy, Nos. 219 and 5195; Decision and Order , 77 Fed. 62,316, 62,342 (Oct. Holiday CVS , 77 Fed. Complaint ¶ 62.

Pharmacy 139

Pharmacy Government Treatment Compliance 139

Eye on FDA

JUNE 14, 2023

The agency acknowledged that full risk information was presented on the webpage, but felt that did not mitigate the overall characterization that minimized risk. It may be that the agency has focused resources on areas that present the highest risk and impact, and that this is not one of those areas. There are no apparent answers.

FDA 82

FDA Production Doctors Treatment 82

Perficient: Drug Development

JANUARY 2, 2024

I don’t think you’ll ever meet anyone who says they like to go to the hospital or to their doctor. As consumers, we’re inclined to minimize return visits to the doctor’s office whenever possible. Post-Discharge Wellness Imagine you recently went to your doctor because you were feeling a little stressed related to life and work.

Doctors 52

Doctors Production Hospitals Marketing 52

FDA Law Blog: Drug Discovery

DECEMBER 7, 2022

Thus, the current reality of gene therapy products presents a conundrum to FDA: If you have an efficacious one-time treatment, how long do you wait to see if the treatment stops working or stops working as well, while patients receive very real benefits in the interim?

Therapies 119

Therapies FDA FDA Approval Treatment 119

Perficient: Drug Development

JANUARY 23, 2024

However, this presents some challenges. This also presents an opportunity for the next use case below. When you visit a doctor and need medication, the doctor will write a script and send it to a local pharmacy to be filled. Okay, I’m sure there are a few things but it’s still inconvenient, right?

Pharmacy 52

Pharmacy Doctors Production Science 52

biobide

FEBRUARY 2, 2024

Some pediatric cancers, such as leukemias, present a high survival percentage with the available treatment regimens but cause systemic toxicities, and a subset of patients eventually relapse. Zebrafish Pioneers Advance in Pediatric Cancer Research and Treatment Increasing the survival rate is the primary goal when screening for cancer drugs.

Disease 59

Disease Medical Schools Pharma Companies Clinical Trials 59

The Pharma Data

DECEMBER 3, 2020

Her mom noticed her face was drooping and rushed her to the hospital, where doctors told her she’d had a stroke. At the hospital, doctors confirmed Keenan had another stroke. Many relatives on her mom’s side have had strokes, and doctors told her it might be genetic. “I felt devastated,” she said.

Doctors 52

Doctors Hospitals Therapies 52

Alta Sciences

JUNE 11, 2024

Attendees were encouraged to engage in several talks and presentations throughout the day, and the event organizers had done a fantastic job assembling an outstanding lineup of speakers/key industry leaders to spark extensive discussions. Of all the high-quality presentations I attended, two in particular caught my attention.

Therapies 52

Therapies Molecular Biology Immune Response Science 52

The Pharma Data

AUGUST 10, 2021

The Tomorrow’s Innovators strategic alliance presents a meaningful opportunity to build the talent pipeline that will not only address the lack of representation in the biopharma industry, but also equip the industry to meet the challenges of the future,” said Danielle Winchester, Associate Dean, Willie A. and the Doctor of Physical Therapy.

Doctors 52

Doctors Engineering Science Pharmacy 52

Drug Target Review

MARCH 28, 2024

Accelerating characterisation While there is substantial evidence supporting natural products as a high-quality source of potential drug leads, the process of discovering such molecules presents various challenges, including the scope of unknown chemistry and biological function.

Production 128

Production Drugs Small Molecule Bioinformatics 128

The Pharma Data

SEPTEMBER 10, 2021

today announced that data from its robust neuroscience portfolio will be presented at the International Parkinson and Movement Disorder Society (MDS) Virtual Congress 2021, taking place September 17-22. More than 20 abstracts across disease states, including Parkinson’s disease, spasticity and cervical dystonia, will be presented.

Doctors 52

Doctors Clinical Trials Disease Therapies 52

The Pharma Data

MARCH 30, 2021

The Phase 3 long-term safety study will be presented at the American Academy of Neurology 2021 Virtual Annual Meeting. The study results were announced in a July 2020 press release and presented at the 2020 Virtual Migraine Trust International Symposium. Using BOTOX® with certain other medicines may cause serious side effects.

Treatment 52

Treatment FDA Doctors FDA Approval 52

The Pharma Data

NOVEMBER 10, 2020

Both studies are scheduled to be presented Nov. Findings presented at meetings are typically considered preliminary until published in a peer-reviewed journal. Heart patients might instead want to lay off pot, Yoo said, or at least make sure doctors know they use marijuana if they wind up needing another procedure.

Doctors 52

Doctors Hospitals Pharmacy Research 52

PPD

MAY 18, 2023

The care partners are the decision-makers for their loved ones with neurodegenerative disorders, handling everything from daily routines and medication management to doctor visits. For neurodegenerative disease research, the care partner, or caregiver, is equally important as the person with dementia.

Clinical Trials 86

Clinical Trials Trials Clinical Research Doctors 86

Broad Institute

JULY 20, 2023

The study has been recruiting and collecting genetic and phenotypic data from children with neurodevelopmental conditions, such as autism, from around Kilifi, Kenya and Cape Town to look for connections between genetics and the clinical presentations of neurodevelopmental conditions. What are some of the standout results from the first year?

Research 98

Research Doctors Disease 98

Olympian Clinical Research

DECEMBER 1, 2022

To help relieve the itching and inflammation associated with plaque psoriasis, your doctor may prescribe a topical ointment or steroid. If you are experiencing generalized pustular psoriasis, contact your doctor immediately, as it may be severe and can lead to serious health complications. Nail Psoriasis. Erythrodermic Psoriasis.

Clinical Trials 52

Clinical Trials Doctors Clinical Research Treatment 52

The Pharma Data

JANUARY 1, 2021

Talk to a doctor about FDA-approved medications to help you quit. “The COVID-19 pandemic presents an opportunity for people, when they’re ready, to find the proven quit smoking support they need,” said Harold Wimmer, the association’s president and CEO. Every smoker can quit. ” © 2021 HealthDay.

FDA Approval 52

FDA Approval Doctors FDA Production 52

The Pharma Data

DECEMBER 9, 2020

9, 2020 — Side effects of radiation therapy in breast cancer patients are often missed by doctors, U.S. The chances of this happening were much higher among Black patients and younger patients, according to the study to be presented Wednesday at the San Antonio Breast Cancer Symposium. WEDNESDAY, Dec. researchers report.

Therapies 52

Therapies Doctors Research Treatment 52

Drug Target Review

SEPTEMBER 22, 2023

This heterogeneity, present within the same structure or between various organoids, could complicate our understanding of specific mechanisms of action when testing novel drugs in vitro. Prior to joining Beckman Coulter Life Sciences, she worked as a Research Associate and Postdoctoral Fellow at Indiana University School of Medicine.

Clinical Research 116

Clinical Research Research Drug Development Molecular Biology 116

Drug Target Review

FEBRUARY 29, 2024

The rigors of training as a physician-scientist present their share of obstacles to overcome. As a growing field, gene therapy also presents its challenges and I have made personal sacrifices along the way. In many STEM graduate programs today, even more women are matriculating, earning doctoral degrees, and advancing into academia.

Therapies 111

Therapies Disease Clinical Trials Science 111